Talarozole is primarily used in the treatment of skin conditions, particularly those related to excessive keratinization, such as psoriasis and ichthyosis. It works by inhibiting the activity of retinoic acid-metabolizing enzymes, leading to increased levels of retinoic acid in the skin. This helps normalize skin cell growth and differentiation, reducing the symptoms of these conditions. Additionally, Talarozole has shown potential in the treatment of acne vulgaris by regulating sebum production and improving skin texture. Its ability to modulate retinoic acid levels also makes it a candidate for research in other dermatological and systemic diseases where retinoic acid signaling plays a critical role.